Life Sciences Community Advances Toward Next Phase of Innovation at Veeva R&D and Quality Summit

Rhea-AI Summary

Veeva Systems (NYSE: VEEV) has announced the upcoming 2024 Veeva R&D and Quality Summit in Boston on Sept. 9-10. This event, one of the largest in life sciences, will bring together over 2,000 industry professionals to discuss how connected systems across clinical, regulatory, safety, and quality can advance drug development.

Keynote speakers from leading companies like AbbVie, Astellas, Eikon Therapeutics, Merck & Co., Moderna, and Roche will share insights on various topics. These include pharmacovigilance transformation, clinical process optimization, scalable development foundations, quality control modernization, and AI-powered translation for faster submissions.

Veeva CEO Peter Gassner will headline the opening keynote, focusing on how connected data and systems can streamline drug development and accelerate product time to market. The summit will feature over 100 sessions, providing ample networking and learning opportunities for attendees.

AbbVie, Astellas, Eikon, Merck, Moderna, Roche, and more share new ideas to advance drug development

PLEASANTON, Calif., Aug. 13, 2024 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced that industry leaders from AbbVie, Astellas, Eikon Therapeutics, Merck & Co., Moderna, and Roche will keynote at the upcoming 2024 Veeva R&D and Quality Summit in Boston on Sept. 9-10. Professionals across life sciences will come together to discuss how connected systems across clinical, regulatory, safety, and quality can move the industry forward for the benefit of patients.

Veeva R&D and Quality Summit is one of the largest life sciences events, drawing more than 2,000 executives to network and learn across more than 100 sessions. Veeva CEO Peter Gassner headlines the opening keynote, sharing innovations and examples of how connected data and systems can significantly streamline drug development and accelerate product time to market. Additional featured keynotes and sessions include:

• AbbVie and Merck discuss the impact of pharmacovigilance transformation on operational visibility and end-to-end efficiency.
  
  
• Astellas explains its holistic approach to driving end-to-end clinical processes for increased speed and transparency.
  
  
• Eikon Therapeutics highlights the benefits of establishing a foundation for scalable and efficient development from clinical trial to product launch.
  
  
• Neurogene and Verve Therapeutics discuss modernizing quality control with simplified processes and digital-first quality execution.
  
  
• Sanofi showcases leveraging AI-powered translation for faster submission timelines.
  
  
• UCB shares its enterprise eCOA journey to accelerate delivery and standardize patient data capture.

"Veeva is committed to customer success, delivering integrated software, data, and services that can advance innovation for patients in need," said Jim Reilly, vice president of Veeva Development Cloud strategy. "Veeva R&D and Quality Summit brings the industry together to share learnings, fresh ideas, and new strategies to improve collaboration and accelerate the delivery of novel products."

The event is open exclusively to life sciences professionals. Register and stay up to date on the agenda at veeva.com/Summit.

Additional Information
Register for Veeva R&D and Quality Summit: veeva.com/Summit/register 
Connect with Veeva on LinkedIn: linkedin.com/company/veeva-systems

About Veeva Systems
Veeva is the global leader in cloud software for the life sciences industry. Committed to innovation, product excellence, and customer success, Veeva serves more than 1,000 customers, ranging from the world's largest biopharmaceutical companies to emerging biotechs. As a Public Benefit Corporation, Veeva is committed to balancing the interests of all stakeholders, including customers, employees, shareholders, and the industries it serves. For more information, visit veeva.com.

Contact:

Deivis Mercado
Veeva Systems
925-226-8821
deivis.mercado@veeva.com

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/life-sciences-community-advances-toward-next-phase-of-innovation-at-veeva-rd-and-quality-summit-302220776.html

SOURCE Veeva Systems

FAQ

When and where is the 2024 Veeva R&D and Quality Summit taking place?

The 2024 Veeva R&D and Quality Summit is scheduled for September 9-10, 2024, in Boston.

Which companies are keynoting at the Veeva R&D and Quality Summit 2024?

Keynote speakers will be from AbbVie, Astellas, Eikon Therapeutics, Merck & Co., Moderna, and Roche, along with Veeva Systems (VEEV) CEO Peter Gassner.

What topics will be discussed at the Veeva R&D and Quality Summit 2024?

The summit will cover topics such as connected systems in clinical, regulatory, safety, and quality areas, pharmacovigilance transformation, clinical process optimization, scalable development, quality control modernization, and AI-powered translation for submissions.

How many attendees are expected at the Veeva R&D and Quality Summit 2024?

The summit is expected to draw more than 2,000 executives from the life sciences industry.

How can life sciences professionals register for the Veeva R&D and Quality Summit 2024?

Life sciences professionals can register for the summit at veeva.com/Summit/register.